Pharma channel feed

As gov­ern­ment fund­ing dries up, Pfiz­er ex­pects to charge pri­vate pay­ers $110+ for Covid-19 vac­cine

3 years ago
Coronavirus

In­de­gene ac­quires first health­care ad agency, pick­ing up physi­cian and con­sumer mar­ket­ing ex­per­tise

3 years ago
Marketing

Take­da sues Apo­tex over prospec­tive gener­ic ver­sions of its top leukemia drug

3 years ago
Law

ICER calls out three drugs from BMS and Lil­ly in re­port on un­sup­port­ed price in­creas­es in Cal­i­for­nia

3 years ago

Preap­proval and oth­er man­u­fac­tur­ing in­spec­tions: FDA re­vis­es two com­pli­ance guides

3 years ago
Manufacturing

Phar­ma TV ad spend­ing dips slight­ly in third quar­ter, but still trend­ing ahead of 2021

3 years ago
Marketing

Clin­i­cal tri­al co­or­di­na­tors sen­tenced to prison af­ter da­ta fal­si­fi­ca­tion scheme

3 years ago
Law

Mer­ck KGaA's French af­fil­i­ate in­dict­ed over in­ves­ti­ga­tion in­to re­for­mu­la­tion case

3 years ago

New Tor­rent Phar­ma­ceu­ti­cals Form 483 high­lights clean­ing and oth­er qual­i­ty is­sues

3 years ago
FDA+
Manufacturing

Un­san­i­tary con­di­tions and oth­er QC is­sues raised by FDA in a warn­ing to con­tract pack­ager

3 years ago
FDA+
Manufacturing

Up­dat­ed: Zymeworks want­ed a Big Phar­ma part­ner for its bis­pe­cif­ic. Jazz Phar­ma­ceu­ti­cals said OK

3 years ago
Deals

J&J holds off on volatile M&A mar­ket but has plen­ty of cash for a deal

3 years ago
R&D

Roche CEO: As­sume 'sharp de­cline' in Covid-re­lat­ed sales next year

3 years ago

Dis­ease aware­ness daze: Do pa­tients and peo­ple tune out health con­di­tion months and re­lat­ed mar­ket­ing?

3 years ago
Marketing

Mar­ket­ingRx roundup: No­var­tis spot­lights breast can­cer pa­tient sto­ries; Cal­i­for­nia al­lots $40M for opi­oid ad cam­paign

3 years ago
Marketing

Adder­all sup­ply woes con­tin­ue as the FDA con­firms short­age of im­me­di­ate re­lease cap­sules

3 years ago
Manufacturing

ICER on MS drugs: TG's ubli­tux­imab not cost ef­fec­tive at the same price as Roche's ocre­lizum­ab

3 years ago

Spring­Works’ first aware­ness cam­paign res­onates for pa­tients with rare soft tis­sue tu­mor

3 years ago
Marketing

Bio­haven rais­es OCD aware­ness us­ing re­al pa­tients in clin­i­cal tri­al ad cam­paign

3 years ago
Marketing

CHMP of­fers pos­i­tive opin­ion for two high-pro­file drugs as part of lat­est batch of rec­om­men­da­tions

3 years ago

‘Phar­ma burnout’: In­dus­try rep­u­ta­tion slumps in first half of 2022, study finds

3 years ago
Marketing

Supreme Court re­jects No­var­tis' re­quest for stay in Gilenya patent bat­tle

3 years ago
Law

Pres­i­dent Biden of­fers an­oth­er push on drug price sav­ings via ex­ec­u­tive or­der

3 years ago

Biosim­i­lar ap­provals on the rise af­ter a two-year slump — Am­gen re­port

3 years ago
First page Previous page 166167168169170171172 Next page Last page
A service from the Financial Times